{"id":509042,"date":"2021-07-01T16:04:10","date_gmt":"2021-07-01T20:04:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\/"},"modified":"2021-07-01T16:04:10","modified_gmt":"2021-07-01T20:04:10","slug":"caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\/","title":{"rendered":"CareDx Transplant Patient App, AlloCare, Expands Access to the Majority of Transplant Patients"},"content":{"rendered":"<h2>\nAlloCare launches in Android Play Store, and is now available on both iOS and Android for all transplant patients<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"left\">SOUTH SAN FRANCISCO, Calif., July  01, 2021  (GLOBE NEWSWIRE) &#8212; CareDx, Inc.\u00a0(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced that AlloCare, the app developed by CareDx for patients looking to manage their health before and after a transplant, has now launched on Android.<\/p>\n<p>AlloCare is an easy-to-use mobile app designed to help organ transplant patients manage their health throughout the pre to post transplant journey with their mobile device. AlloCare allows patients to manage medications, schedule lab appointments, and view test results. Additionally, the app monitors biometrics and provides a platform for community engagement. With the launch on Android, the total addressable user base doubles.<\/p>\n<p>\u201cWhen we created this app, we wanted to make sure it would serve transplant recipients well, so we involved them in the design, testing, and implementation process,\u201d said Sasha King, Chief Marketing Officer, CareDx. \u201cThanks to the help, insights and experience from patient organizations, including Transplant Recipients International Organization (TRIO), we have put together a truly patient-focused app that is specific to the needs before and after transplantation.\u201d<\/p>\n<p>\u201cTRIO members have been involved with the design and testing of the AlloCare app for almost a year. By listening to real transplant patients, they\u2019ve been able to build a comprehensive app that is customizable to various needs of patients whether they are still on the transplant waitlist or 20 years post-transplant,\u201d said Jim Gleason, TRIO president and a heart transplant recipient.<\/p>\n<p>Users can download the app in the iOS or Android app stores now. To learn more about AlloCare, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gm3GcGQFFS3LDnkLLK9dK1V6UuV4bKoaD4pAS2WtYYvS3yfzbIdXhPNX95mzoObPsL7m5bBV5oEmSxGva7TDY_idchxRDTGfzVsjV0ypBG4=\" rel=\"nofollow noopener\" target=\"_blank\">www.caredx.com\/allocare<\/a>.<\/p>\n<p>\n        <strong>About\u00a0CareDx<\/strong><br \/>\n        <br \/>CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=I6jsMNzIZXvxxTUCYWPofpx7phFtnKxaMV9mvV-hwdowJdPGht_-oHWuWb1SeSwTNCYEEPTp9odBkYUk9SS1VFFzLfrRXazyoFYMfZThyHVy8cCgP54MGfC0xLPP0CL5Lfemf6teIssqxxbSyqaOWDLSl171bk4JLUCaY1hbSFcI9eRbPTfsF5IFgaSW-2PF-b_BdB6DbPjZqAfXxmXpHuNUiX06kH_Y6Sab2ztXnl0=\" rel=\"nofollow noopener\" target=\"_blank\">www.CareDx.com<\/a>.<\/p>\n<p>\n        <strong>CONTACTS:<\/strong><br \/>\n        <br \/>CareDx, Inc.<br \/>Sasha King<br \/>Chief Marketing Officer<br \/>415-287-2393<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Cj6ZY7eDkrZtXFPd9FbTpmeSod-klqGwxB0bv9j-9x8B_MOqRbFgNjVXJ_f9fj9sx7LimYUXCQjRv0Ef07kUiQ==\" rel=\"nofollow noopener\" target=\"_blank\"><u>sking@caredx.com<\/u><\/a><\/p>\n<p>Investor Relations<br \/>Greg Chodaczek<br \/>347-920-7010<br \/><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bZ6eOL6dGlEgOzJnD-3_p8lf1Gr0KokZT0Hd--onJGZ-PWGUKHX1Ue_v_Wqn8N-kLFwWaFZ8V-Pga3HTK61jtyDBgBH5kF2qHWlWMAAGi-k=\" rel=\"nofollow noopener\" target=\"_blank\">investor@caredx.com<\/a><\/u><\/p>\n<p>\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NDIwMyM0Mjc5NzA5IzIwMDQ1MDM=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/ea1e0006-852d-42b4-bda0-fa8dcd96609d\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>AlloCare launches in Android Play Store, and is now available on both iOS and Android for all transplant patients SOUTH SAN FRANCISCO, Calif., July 01, 2021 (GLOBE NEWSWIRE) &#8212; CareDx, Inc.\u00a0(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced that AlloCare, the app developed by CareDx for patients looking to manage their health before and after a transplant, has now launched on Android. AlloCare is an easy-to-use mobile app designed to help organ transplant patients manage their health throughout the pre to post transplant journey with their mobile device. AlloCare allows patients to manage medications, schedule lab appointments, and view test results. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;CareDx Transplant Patient App, AlloCare, Expands Access to the Majority of Transplant Patients&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-509042","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CareDx Transplant Patient App, AlloCare, Expands Access to the Majority of Transplant Patients - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CareDx Transplant Patient App, AlloCare, Expands Access to the Majority of Transplant Patients - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"AlloCare launches in Android Play Store, and is now available on both iOS and Android for all transplant patients SOUTH SAN FRANCISCO, Calif., July 01, 2021 (GLOBE NEWSWIRE) &#8212; CareDx, Inc.\u00a0(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced that AlloCare, the app developed by CareDx for patients looking to manage their health before and after a transplant, has now launched on Android. AlloCare is an easy-to-use mobile app designed to help organ transplant patients manage their health throughout the pre to post transplant journey with their mobile device. AlloCare allows patients to manage medications, schedule lab appointments, and view test results. &hellip; Continue reading &quot;CareDx Transplant Patient App, AlloCare, Expands Access to the Majority of Transplant Patients&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-01T20:04:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NDIwMyM0Mjc5NzA5IzIwMDQ1MDM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"CareDx Transplant Patient App, AlloCare, Expands Access to the Majority of Transplant Patients\",\"datePublished\":\"2021-07-01T20:04:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\\\/\"},\"wordCount\":384,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3NDIwMyM0Mjc5NzA5IzIwMDQ1MDM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\\\/\",\"name\":\"CareDx Transplant Patient App, AlloCare, Expands Access to the Majority of Transplant Patients - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3NDIwMyM0Mjc5NzA5IzIwMDQ1MDM=\",\"datePublished\":\"2021-07-01T20:04:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3NDIwMyM0Mjc5NzA5IzIwMDQ1MDM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3NDIwMyM0Mjc5NzA5IzIwMDQ1MDM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CareDx Transplant Patient App, AlloCare, Expands Access to the Majority of Transplant Patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CareDx Transplant Patient App, AlloCare, Expands Access to the Majority of Transplant Patients - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\/","og_locale":"en_US","og_type":"article","og_title":"CareDx Transplant Patient App, AlloCare, Expands Access to the Majority of Transplant Patients - Market Newsdesk","og_description":"AlloCare launches in Android Play Store, and is now available on both iOS and Android for all transplant patients SOUTH SAN FRANCISCO, Calif., July 01, 2021 (GLOBE NEWSWIRE) &#8212; CareDx, Inc.\u00a0(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced that AlloCare, the app developed by CareDx for patients looking to manage their health before and after a transplant, has now launched on Android. AlloCare is an easy-to-use mobile app designed to help organ transplant patients manage their health throughout the pre to post transplant journey with their mobile device. AlloCare allows patients to manage medications, schedule lab appointments, and view test results. &hellip; Continue reading \"CareDx Transplant Patient App, AlloCare, Expands Access to the Majority of Transplant Patients\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-01T20:04:10+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NDIwMyM0Mjc5NzA5IzIwMDQ1MDM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"CareDx Transplant Patient App, AlloCare, Expands Access to the Majority of Transplant Patients","datePublished":"2021-07-01T20:04:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\/"},"wordCount":384,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NDIwMyM0Mjc5NzA5IzIwMDQ1MDM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\/","name":"CareDx Transplant Patient App, AlloCare, Expands Access to the Majority of Transplant Patients - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NDIwMyM0Mjc5NzA5IzIwMDQ1MDM=","datePublished":"2021-07-01T20:04:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NDIwMyM0Mjc5NzA5IzIwMDQ1MDM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NDIwMyM0Mjc5NzA5IzIwMDQ1MDM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"CareDx Transplant Patient App, AlloCare, Expands Access to the Majority of Transplant Patients"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/509042","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=509042"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/509042\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=509042"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=509042"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=509042"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}